Our squeeze scans are lighting up with parabolic setups
By Sam Gatlin
January 29, 2026
Investors aren’t hiding in safety.
They’re reaching for risk, piling into the most speculative, most hated corners of the market.
This is creating a dangerous problem for short sellers who have leaned too aggressively against this market, and now they’re being forced to cover as prices rip higher.
That kind of panic is exactly what powers our Freshly Squeezed strategy, which targets the juiciest short-squeeze setups before they go vertical.
And right now, we’re seeing some of the best opportunities this cycle lighting up our scans.
Here's our latest scan:
As you can see, Corvus Pharmaceuticals $CRVS, Ambitions Enterprise $AHMA, and ImmunityBio $IBRX are at the top of the leaderboard.
Over the last 10 trading sessions, they've rallied 216%, 155.8%, and 118.1%, respectively.
These are precisely the kinds of parabolic moves we aim to catch early.
We’re also tracking squeeze candidates by short interest and days-to-cover, two critical ingredients for sustained upside. These are where the next squeezes will come from.
When high short interest meets low liquidity, it doesn’t take much to send a stock into orbit.
Today, we have three Freshly Squeezed setups that look poised to surge higher.
Premium members can see the entry and target levels below. 👇
You need to have a subscription to access this content in full.
Log in or subscribe today to unlock new features and receive Member Benefits.
